Docetaxel With or Without Oblimersen in Treating Patients With Hormone-Refractory Adenocarcinoma (Cancer) of the Prostate
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Cora N. Sternberg, MD, FACP
Azienda Ospedaliera S. Camillo-Forlanini
Study Chair
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
16 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Kaiser Franz Josef Hospital
Vienna, Austria
- Onze Lieve Vrouw Ziekenhuis Aalst
Aalst, Belgium
- Cliniques Universitaires Saint-Luc
Brussels, Belgium
- Institut Jules Bordet
Brussels, Belgium
- Universitair Ziekenhuis Gent
Ghent, Belgium
- U.Z. Gasthuisberg
Leuven, Belgium
- Rigshospitalet - Copenhagen University Hospital
Copenhagen, Denmark
- Chu de Grenoble - Hopital de la Tronche
Grenoble, France
- Assaf Harofeh Medical Center
Ẕerifin, Israel
- Ospedale S. Camillo-Forlanini
Rome, Italy
- Academisch Medisch Centrum at University of Amsterdam
Amsterdam, Netherlands
- Maria Sklodowska-Curie Memorial Cancer Center and Institute of Oncology
Warsaw, Poland
- Hospital Desterro
Lisbon, Portugal
- Hospital General Universitari Vall D'Hebron
Barcelona, Spain
- Saint Bartholomew'S Hospital
London, England, United Kingdom
- Western Infirmary
Glasgow, Scotland, United Kingdom
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 30 Apr 2004
- Primary completion
- 31 Jan 2006
- Completion
- —
- Last update posted
- 24 Sept 2012
- Registered enrollment
- 116
- Registry id
- NCT00085228
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.